Slocum, Gordon & Co’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.9K Sell
42
-2
-5% -$138 ﹤0.01% 111
2025
Q1
$3.05K Buy
+44
New +$3.05K ﹤0.01% 122